1
0
0
News
Breast cancer 'signature' predicts response to new drug class
medicalxpress.com
Najoua Lalaoui, Professor John Silke, Professor Jane Visvader and Professor Geoff Lindeman. Professor Lindeman is also a medical oncologist ...
Combination Therapy is Powerful In Treating Cancer : Research
www.magzter.com
Read this exciting story from Microbioz India June An international team of researchers has found a new and unique approach to improving the anti-cancer...
Existing drugs could offer new way to treat severe inflammatory skin...
www.news-medical.net
Existing medicines could offer a new way to treat inflammatory skin conditions, researchers at Melbourne's Walter and Eliza Hall Institute and the Royal...
Combination approach improves power of new cancer therapy
medicalxpress.com
Dr Najoua Lalaoui (L) and Professor John Silke were part of an ... was the outcome of a research collaboration between Dr Najoua Lalaoui, ...
Netzwerk-Profile
LinkedIn: Najoua Lalaoui – Senior Post Doctoral Research Fellow – WEHI-Silke ...
Sehen Sie sich das Profil von Najoua Lalaoui auf LinkedIn an, dem weltweit größten beruflichen Netzwerk. 4 Jobs sind im Profil von Najoua Lalaoui aufgelistet.
LinkedIn: Najoua Lalaoui | Berufsprofil - LinkedIn
Najoua Lalaoui. Post Doctoral Research Fellow chez WEHI. Standort: Melbourne und Umgebung, Australien; Branche: Forschung ...
LinkedIn: Najoua Lalaoui - Senior Post Doctoral Research Fellow LinkedIn
community. Najoua has 4 jobs listed on their profile. See the complete profile on
...
Private Homepages
Use your cancer experience to help others | Cancer Council Victoria
www.cancervic.org.au
If you’ve been a carer or diagnosed with cancer, leading research institutes need your help to improve cancer outcomes.
Ausbildung
Najoua LALAOUI, 41 ans (MELBOURNE, DIJON) - Copains d'avant
copainsdavant.linternaute.com
LALAOUI Najoua : Najoua LALAOUI, née en et habite MELBOURNE. Aux dernières nouvelles elle était à Inserm à DIJON et elle y est toujours.
Bücher
Advances in TNF Family Research: Proceedings of the 12th...
books.google.at
The biennial TNF-family conferences have been held over the past 20 years, from the time that TNF was cloned. These meetings have followed the enormous...
Connecting the Dots Between Inflammation and the Inner Workings of ...books.google.ch › books
books.google.ch
... University of Bern, Switzerland Reviewed by: Gustavo P. Amarante-Mendes, University of São Paulo, Brazil Najoua Lalaoui, Walter and Eliza Hall Institute ...
Connecting the Dots Between Inflammation and the Inner Workings of...
books.google.dk
... Switzerland Reviewed by: Gustavo P. Amarante-Mendes, University of São Paulo, Brazil Najoua Lalaoui, Walter and Eliza Hall Institute of Medical Research, ...
Dokumente zum Namen
Oral Presentation — ASN Events
cancer-2018.p.asnevents.com.au
cancers (#4). Najoua Lalaoui , Delphine Merino , Francois Vaillant , GOKNUR ...
Targeting p38 or MK2 Enhances the Anti-Leukemic Activity of...
www.scienceopen.com
Authors: Najoua Lalaoui, Kay Hänggi, Gabriela Brumatti, Diep Chau, Nhu-Y N Nguyen, Lazaros Vasilikos, Lisanne M Spilgies, Denise A Heckmann, Chunyan ...
Wissenschaftliche Veröffentlichungen
Seminars in Cell & Developmental Biology | Mechanisms and...
www.sciencedirect.com
The molecular relationships between apoptosis, autophagy and necroptosis. Review article: Pages Najoua Lalaoui, Lisa M. Lindqvist, Jarrod J. Sandow, ...
Combination approach improves power of new cancer therapywww.sciencedaily.com › releases ›
www.sciencedaily.com
· The research, recently published in the journal Molecular Cell, was the outcome of a research collaboration between Dr Najoua Lalaoui, ...
New human autoinflammatory disease -- ScienceDaily
www.sciencedaily.com
The research team was led by Dr Najoua Lalaoui and Professor John Silke from the Walter and Eliza Hall Institute of Medical Research, ...
Veröffentlichungen allgemein
Najoua Lalaoui - theses.frwww.theses.fr › ...
www.theses.fr
Régulation de la voie TRAIL par le récepteur leurre DcR2. par Najoua Lalaoui sous la direction de Olivier Micheau - Dijon ...
theses.fr – Najoua Lalaoui , Régulation de la voie TRAIL par le...
www.theses.fr
TRAIL is regarded as a promising anticancer agent for cancer therapy due to its selective anti-tumoral properties. This cytokine is one of several members of...
Blood Cancer News Issue 2 - Leukaemia Foundation Queensland
www.leukaemiaqld.org.au
The combination of birinapant and p38 inhibitors has shown promise in preclinical studies as a new treatment for acute myeloid leukaemia (AML). Dr Najoua Lalaoui, Professor John Silke and colleagues from the Walter and Eliza Hall. Institute discovered the combination of p38 inhibitors and birinapant had a much stronger.
Artikel & Meinungen
nature.com search
www.nature.com
Linear ubiquitin chain assembly complex coordinates late thymic T-cell differentiation and regulatory T-cell homeostasis · Charis E. Teh; , Najoua Lalaoui ...
ApoList – February – Apoptosis and cell death
celldeath.wordpress.com
Maria C Tanzer, Nufail Khan, James A Rickard, Nima Etemadi, Najoua Lalaoui, Sukhdeep Kaur Spall, Joanne M Hildebrand, David Segal, ...
Inaugural winners of the Peer Prize for Women in Science | by Ben...
medium.com
To be a catalyst for inspiring women researchers in Australia, we were very excited to host the the inaugural Peer Prize for women in science, supported by the...
Sonstiges
Najoua Lalaoui - Google Scholar Citationsscholar.google.com.au › citations
scholar.google.com.au
View all. Follow. Najoua Lalaoui. Post doc fellow, WEHI. Verified email at wehi.edu.au. ApoptosisNecroptosisCancerinflammation. ArticlesCited byCo-authors ...
WO A1 - Method of treating cancer Google Patents
patents.google.com
Other languages: English: French; Inventor: Najoua LALAOUI: John Henry SILKE: David Laurence Vaux; Original Assignee: The Walter And Eliza Hall Institute ...
Dr Najoua Lalaoui - Latest research stories and news | Pursuit by...
pursuit.unimelb.edu.au
· Dr Najoua Lalaoui. Senior Post Doctoral Research Fellow, Walter and Eliza Hall Institute; Honorary, Department of Medical Biology, ...
Najoua Lalaoui — ASN Events
mpg-postdoc-2012.p.asnevents.com.au
Najoua Lalaoui Melbourne Protein Group 2nd Postdoctoral Symposium Days; Thursday, 20th September. Search; Speakers ...
Najoua Lalaoui | University of Melbourne - Academia.edu
unimelb.academia.edu
Academia.edu is a place to share and follow research.
Najoua Lalaoui - Thinkable.orgwww.thinkable.org › users › najou...
www.thinkable.org
Najoua Lalaoui (Najoua Lalaoui). Verified Researcher. Image ? Walter+Eliza Hall Institute of Medical Research ...
Dr Najoua Lalaoui - Cell Death and Signalling division | WEHI
www.wehi.edu.au
Targeting IAPs and p38 MAPK to treat cancer
Dr Najoua Lalaoui | WEHIwww.wehi.edu.au › dr-najoua-lalaoui
www.wehi.edu.au
We acknowledge the Wurundjeri people of the Kulin Nation as the traditional owners of the land where our campuses are located, and recognise their continuing ...
najoua.lalaoui - Publications List
publicationslist.org
Delphine Mérino, Najoua Lalaoui, Alexandre Morizot, Eric Solary, Olivier Micheau (2007) TRAIL in cancer therapy: present and future challenges.
CRIA-Syndrom | FMF & AID
de.fmfandaid.org
Die Forschungsteams unter der Leitung von Dr. Najoua Lalaoui und Professor John Silke vom Walter and Eliza Hall Institut für medizinische Forschung in ...
Chemotherapy overcomes TRAIL-R4-mediated TRAIL resistance at the DISC...
hal.inria.fr
Alexandre Morizot 1 Delphine Mérino 1 Najoua Lalaoui 1 Guillaume Jacquemin 1 Virginie Granci 1 Elisabetta Iessi 1 David Lanneau 1 Florence Bouyer 1 Eric ...
Differential inhibition of TRAIL-mediated DR5-DISC formation by decoy...
www.hal.inserm.fr
1 and 2. Delphine Mérino 1, 2, 3 Najoua Lalaoui 1, 2, 3 Alexandre Morizot 1, 2, ...
Create a SciFeed alert for new publications - MDPIwww.mdpi.com › scifeed_display
www.mdpi.com
Kristiina Nordfors. Joonas Haapasalo. Hannu Haapasalo. Terrance G. Johns. Brett W. Stringer. Bryan W. Day. Michael E. Buckland. Najoua Lalaoui. Lenka Munoz ...
Death Receptor-Induced Apoptosis Signalling Regulation by Ezrin Is ...journals.plos.org › plosone › article › journal.pone....
journals.plos.org
Sarah Shirley,; Najoua Lalaoui,; Selene L. Elifio-Esposito. PLOS. x. Published: May 26, 2015; https://doi.org journal.pone
Combination Improves Anticancer Activity of 2 Agents in Acute Myeloid...
www.oncologynurseadvisor.com
"Both p38 inhibitors and birinapant have been safely used in humans in clinical trials," said Najoua Lalaoui, PhD, of the Hall Institute, and first ...
Defining regulators of cell death and inflammasome activationhudson.org.au › research-project › defining-regulat...
hudson.org.au
... flow cytometry, ELISA and qPCR. Collaborators: Paul Hertzog (Hudson Institute), James Vince, John Silke, Najoua Lalaoui (WEHI), Monica Yabal (Munich) ...
CRIA Syndrome | FMF & AID
www.fmfandaid.org
Najoua Lalaoui and Professor John Silke from the Walter and Eliza Hall Institute of Medical Research in Australia, and Dr. Steven Boyden, Dr. Hirotsugu Oda and ...
Altmetric – Targeting p38 or MK2 Enhances the Anti-Leukemic Activity...
monash.altmetric.com
Najoua Lalaoui, Kay Hänggi, Gabriela Brumatti, Diep Chau, Nhu-Y.N. Nguyen, Lazaros Vasilikos, Lisanne M. Spilgies, Denise A. Heckmann, Chunyan Ma, ...
Centre Georges Francois Leclerc - TRAIL-R4 promotes tumor ...tel.archives-ouvertes.fr › CGFL
tel.archives-ouvertes.fr
Najoua Lalaoui, Aymeric Morlé, Delphine Mérino, Guillaume Jacquemin, Elisabetta Iessi, et al.. TRAIL-R4 promotes tumor growth and resistance to apoptosis in ...
MK2 inhibition induces p53-dependent senescence in glioblastoma...
research-repository.uwa.edu.au
... Brett W. Stringer, Bryan W. Day, Michael E. Buckland, Najoua Lalaoui, Lenka Munoz. Research output: Contribution to journal › Article › peer-review.
Verwandte Suchanfragen zu Najoua Lalaoui
| Guillaume Jacquemin |
Personen Vorname "Najoua" (24) Name "Lalaoui" (10) |
sortiert nach Relevanz / Datum